Pulmonary fibrosis (PF) is a chronic and ultimately fatal interstitial lung disease of various
causes. The advent of nintedanib and pirfenidone provides treatment options for PF patients …

Idiopathic pulmonary fibrosis is a progressive and lethal form of interstitial lung disease that
lacks effective therapies at present. Glycyrrhizic acid (GA), a natural compound extracted …

Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial
lung diseases with poor prognosis. Currently, few effective drugs are available for IPF …

Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …

Background: To study the protective effects of ganoderic acid A (GAA) on bleomycin (BLM)-
induced pulmonary fibrosis. Methods: ICR mice were intratracheally instilled with BLM to …

Studies have shown that angiotensin-converting enzyme 2 (ACE2) plays modulating roles in
lung pathophysiology, including pulmonary fibrosis (PF) and acute lung injury. Pulmonary …

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin
(AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and …

Pulmonary fibrosis, a potentially fatal disease, results from acute and chronic interstitial lung
diseases. Fucoxanthin (Fx), a carotenoid found in brown seaweed, shows a wide range of …

Bleomycin (BLM) is a chemotherapeutic agent which is associated with Idiopathic
pulmonary fibrosis (IPF) due to its chronic administration. Hesperidin, a bioflavonoid has …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial pneumonia that causes pulmonary
tissue damage and functional impairment. To investigate the effects of cryptotanshinone on …